These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 101503)

  • 21. Evaluation of different antibiotic actions combined with rifampicin. In vitro synergism against Pseudomonas and Proteus.
    Urena MT; Barasoain I; Espinosa M; Garcia E; Portoles A
    Chemotherapy; 1975; 21(2):82-9. PubMed ID: 169107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical use of nalidixic acid. A review and some observations.
    Stamey TA; Nemoy NJ; Higgins M
    Invest Urol; 1969 May; 6(6):582-92. PubMed ID: 4976942
    [No Abstract]   [Full Text] [Related]  

  • 23. The in vitro demonstration of the efficacy of trimethoprim as an antibacterial agent in a comparative bacteriological study of the effects of trimethoprim, sulfamethoxazole and the combination trimethoprim-sulfamethoxazole.
    Küchler R; Koch UJ
    Chemotherapy; 1973; 18(4):242-52. PubMed ID: 4571975
    [No Abstract]   [Full Text] [Related]  

  • 24. [Rifampicin in Klebsiella pneumoniae septicemia].
    Jungbluth H; Tögel H
    MMW Munch Med Wochenschr; 1978 Sep; 120(35):1133-4. PubMed ID: 357959
    [No Abstract]   [Full Text] [Related]  

  • 25. [Chemotherapy of urinary tract infections in children and standards for evaluating its efficacy--with special reference to the therapeutic results of cephalexin suspensions].
    Kobayashi Y; Akaishi K; Nishio T; Goto K; Aihara M
    Jpn J Antibiot; 1972 Apr; 25(2):104-19. PubMed ID: 4561052
    [No Abstract]   [Full Text] [Related]  

  • 26. [Urinary tract infections. Experimental production in rats].
    Rosini S; Benetti D
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1972; 65(1):50-8. PubMed ID: 4567281
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of antimicrobial activities of minocycline and rifampin-impregnated silicone surfaces in an in vitro urinary system model.
    Salvarci A; Koroglu M; Gurpinar T
    J Pak Med Assoc; 2015 Feb; 65(2):115-9. PubMed ID: 25842542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laboratory experiments with uropathogenic bacteria and chlorhexidine.
    Korner B; Kühle P; Christensen SC
    Acta Chir Scand Suppl; 1973; 433():110-2. PubMed ID: 4196567
    [No Abstract]   [Full Text] [Related]  

  • 29. Chemotherapeutic activity of rifampin against gram-negative bacteria with reference to urinary-tract infection in rats.
    Konopka EA; Zoganas HC; Lewis L; Gelzer J
    Antimicrob Agents Chemother (Bethesda); 1968; 8():519-23. PubMed ID: 5735400
    [No Abstract]   [Full Text] [Related]  

  • 30. The interaction patterns of combined antibacterial agents. Experiments with two agardiffusion methods.
    Mouton RP; Koelman A
    Chemotherapy; 1966; 11(1):10-26. PubMed ID: 4959585
    [No Abstract]   [Full Text] [Related]  

  • 31. [Nalidixic acid (Wintomylon) and bacterial resistance to antibiotics in urinary tract infections].
    Makino M
    Hinyokika Kiyo; 1968 Jun; 14(6):351-6. PubMed ID: 4882490
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapy results with nalidixic acid in chronic urinary tract infection].
    Broghammer H
    Arzneimittelforschung; 1968 Sep; 18(9):1139-43. PubMed ID: 4885373
    [No Abstract]   [Full Text] [Related]  

  • 33. In vitro sensitivity pattern of gram negative pathogens to nalidixic acid.
    Chitkara YK
    Indian J Pathol Bacteriol; 1969 Oct; 12(4):162-8. PubMed ID: 4990210
    [No Abstract]   [Full Text] [Related]  

  • 34. [Laboratory and clinical studies on cefminox].
    Sawae Y; Okada K; Kumagai Y
    Jpn J Antibiot; 1985 May; 38(5):1155-64. PubMed ID: 3930782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulphadimidine and nalidixic acid therapy in urinary-tract infections in general practice.
    Brown PC; Donaghy MC; Dootson PH; Titcombe DH; MacLaren DM
    Practitioner; 1971 Dec; 207(242):819-26. PubMed ID: 4947233
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of a three-day course of nalidixic acid in the frequency-dysuria syndrome with significant bacteriuria in women.
    Ahlmén J; Sigurdsson J; Wohrm A; Calmenius C; Merck C; Bucht H
    Scand J Infect Dis; 1983; 15(1):71-4. PubMed ID: 6342128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbial resistance to antibiotics used to treat urinary tract infections in Mexican children.
    Hernández-Porras M; Salmerón-Arteaga G; Medina-Santillán R
    Proc West Pharmacol Soc; 2004; 47():120-1. PubMed ID: 15633630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012).
    Sader HS; Farrell DJ; Flamm RK; Jones RN
    J Infect; 2014 Sep; 69(3):266-77. PubMed ID: 24780763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of cefazolin in 45 cases of urinary tract infections.
    Lus RG; Calvo MC; Lopez LG; Cancer RC; Molina AM; Sanchez ED; Parilla AC; Mur LL
    Chemotherapy; 1977; 23(2):106-113. PubMed ID: 318980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative studies in vitro on the antibiotic effectiveness of Terizidon].
    Wewalka G; Rotter M; Werner HP
    Wien Med Wochenschr; 1974 Apr; 124(15):235-8. PubMed ID: 4207337
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.